Adma Biologics ADMA
NASDAQ ADMA
$12.79 +0.06 (+0.47%)
At close: Nov 9, 2026 · 4:00 PM EST

Adma Biologics (ADMA) Change in Accrued Expenses (2011 - 2026)

Updated

Adma Biologics (ADMA) posted Change in Accrued Expenses of $15.15 million for Q3 2026, compared with -$221,000 a year earlier.

Analysis

Adma Biologics (ADMA) Change in Accrued Expenses (2011 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Change in Accrued Expenses at Adma Biologics was $24.31 million; for FY2025, it was $5.21 million, up 400.2% from FY2024.

  • Annual Change in Accrued Expenses shows a five-year compound annual growth rate of 8.9% (FY2020 to FY2025).
  • In prior years, Adma Biologics' Change in Accrued Expenses was $1.04 million in FY2024 (-86.2%), $7.53 million in FY2023 (-0.1%), $7.53 million in FY2022 (-9.7%) and $8.34 million in FY2021 (+145.2%).
  • The Q3 2026 figure stands as the highest quarterly Change in Accrued Expenses in data going back to Q1 2011.
  • The strongest year-over-year quarter for Change in Accrued Expenses in the past five years was Q4 2021, with growth of 258.9%; the weakest was Q3 2023, with a decline of 93.7%.
  • According to Business Quant data, Change in Accrued Expenses for the three prior quarters was -$6.58 million (Q2 2026), $5.11 million (Q1 2026) and $10.64 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 2.41 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 983.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 756.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Adma Biologics 2.87 Bn 2.39 Bn 99.92 Mn 15.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 15.15 Mn
Jun 30, 2026 -6.58 Mn
Mar 31, 2026 5.11 Mn
Dec 31, 2025 10.64 Mn
Sep 30, 2025 -221,000.00
Jun 30, 2025 -2.81 Mn
Mar 31, 2025 -2.40 Mn
Dec 31, 2024 6.43 Mn
Sep 30, 2024 -191,000.00
Jun 30, 2024 -5.97 Mn
Mar 31, 2024 772,000.00
Dec 31, 2023 2.66 Mn
Sep 30, 2023 135,000.00
Jun 30, 2023 6.09 Mn
Mar 31, 2023 -1.35 Mn
Dec 31, 2022 6.87 Mn
Sep 30, 2022 2.13 Mn
Jun 30, 2022 313,905.00
Mar 31, 2022 -1.78 Mn
Dec 31, 2021 2.81 Mn
API Access

Adma Biologics Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ADMA&period=max&api_key=YOUR_API_KEY